Sipai Health Technology Co,

Sipai Health Technology Co, Equity

The The Equity of Sipai Health Technology Co, (314.HK) as of Nov 21, 2026 is 1.23 B CNY. In the previous year, The Equity was 1.62 B CNY — a change of -24.28% (lower).

Equity

1.23 BCNY

YoY

-24.28%

Last updated:

In 2024, Sipai Health Technology Co,'s equity was 1.23 B CNY, a -24.28% increase from the 1.62 B CNY equity in the previous year.

The Sipai Health Technology Co, Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
-1.80 B CNY
Jan 1, 2021
-5.43 B CNY
Jan 1, 2022
1.84 B CNY
Jan 1, 2023
1.62 B CNY
Jan 1, 2024
1.23 B CNY
The Sipai Health Technology Co, Equity history
YEAREquityYoY
1.23 BCNY-24.28%
1.62 BCNY-11.87%
1.84 BCNY-133.83%
-5.43 BCNY+202.19%
-1.80 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sipai Health Technology Co, Stock analysis

What does Sipai Health Technology Co, do? Sipai Health Technology Co., Ltd. generates revenue through its Specialty Pharmacy Business, which operates offline specialty pharmacies and distributes pharmaceutical products to pharmaceutical companies and distributors. The Physician Research Assistance Business offers integrated services to pharmaceutical companies for producing clinical trial data that meets regulatory standards, supporting their progression to later clinical phases or regulatory approvals. The Health Insurance Services Business provides insurance brokerage services, distributing various health and life insurance products on behalf of insurance carriers. These segments collectively serve pharmaceutical companies, healthcare providers, and insurance carriers through specialized offerings in pharmacy distribution, clinical research support, and insurance brokerage. The company's Specialty Pharmacy Business focuses on offline pharmacy operations and pharmaceutical distribution, targeting pharmaceutical companies and distributors as key clients. Physician Research Assistance Business caters to pharmaceutical companies requiring regulatory-compliant clinical trial data for advancing drug development. Health Insurance Services Business partners with insurance carriers to distribute health and life insurance products to end customers, leveraging the company's brokerage platform for insurance product distribution. Sipai Health Technology's business model integrates pharmacy distribution, clinical research support, and insurance brokerage to address specific needs within the healthcare sector. The Specialty Pharmacy Business serves pharmaceutical companies and distributors with offline pharmacy networks and product distribution. Physician Research Assistance Business assists pharmaceutical companies in meeting regulatory requirements for clinical trials, while Health Insurance Services Business facilitates insurance product distribution through brokerage partnerships with carriers. Sipai Health Technology Co, is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sipai Health Technology Co,'s Equity

Sipai Health Technology Co,'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sipai Health Technology Co,'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sipai Health Technology Co,'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sipai Health Technology Co,'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sipai Health Technology Co,’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sipai Health Technology Co, stock

The Equity of Sipai Health Technology Co, is 1.23 B CNY in 2024.

The Equity of Sipai Health Technology Co, changed from 1.62 B CNY to 1.23 B CNY, representing a -24.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sipai Health Technology Co, since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sipai Health Technology Co, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sipai Health Technology Co,

All Key Metrics — Sipai Health Technology Co,